← Eichor
Study identifier: NCT05908812 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Relationship Between Glycemic Control and Irisin in Type 2 Diabetic Patients With Sarcopenic or Non-sarcopenic Obesity

Condition: Sarcopenia · Obesity · Diabetes Mellitus, Type 2  ·  Sponsor: Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

PhaseN/A
Planned participants120
Who can joinAll sexes, 60 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this observational study is to compare glycemic control and irisin levels in subjects with diabetes mellitus type 2 with sarcopenic obesity vs non-sarcopenic obesity. The main questions it aims to answer are: Is glycemic control worse in diabetic patients with sarcopenic obesity? Are irisin levels higher in patients with non-sarcopenic obesity? Participants will be asked to: * Fill in three questionaries on lifestyle * Perform two physical performance tests The investigators will collect the following data: * Anthropometric measurements * Body composition by bioelectrical impedance analysis. * Results of routine blood analyses * Irisin levels by drawing a vial of blood from the antecubital vein

This description comes directly from the study's public registry record.

Talk to the study team

Francesco Giorgino, MD, PhD  ·  +390805593522  ·  francesco.giorgino@uniba.it

Always discuss trial participation with your own doctor first.

Locations (1)

Policlinico di BariBari, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05908812